Tilray Brands, Inc. (ETR:2HQ)
0.9428
-0.0922 (-8.91%)
Aug 15, 2025, 5:35 PM CET
Tilray Brands Revenue
In the fiscal year ending May 31, 2025, Tilray Brands had annual revenue of $821.31M USD with 4.10% growth. Tilray Brands had revenue of $224.54M in the quarter ending May 31, 2025, a decrease of -2.33%.
Revenue
$821.31M
Revenue Growth
+4.10%
P/S Ratio
1.33
Revenue / Employee
$288.99K
Employees
2,842
Market Cap
966.29M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
May 31, 2025 | 821.31M | 32.37M | 4.10% |
May 31, 2024 | 788.94M | 161.82M | 25.80% |
May 31, 2023 | 627.12M | -1.25M | -0.20% |
May 31, 2022 | 628.37M | 115.29M | 22.47% |
May 31, 2021 | 513.09M | 107.76M | 26.59% |
May 31, 2020 | Pro | Pro | Pro |
May 31, 2019 | Pro | Pro | Pro |
May 31, 2018 | Pro | Pro | Pro |
May 31, 2017 | Pro | Pro | Pro |
May 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.22B |
Bayer Aktiengesellschaft | 46.17B |
Fresenius SE & Co. KGaA | 22.28B |
Sartorius Aktiengesellschaft | 3.47B |
Fresenius Medical Care AG | 19.52B |
Fielmann Group AG | 2.33B |
Carl Zeiss Meditec AG | 2.18B |
Tilray Brands News
- 1 day ago - Tilray Brands Reconfirms Strategy to Regain Nasdaq Compliance; Requests Extension to Meet Listing Requirements - GlobeNewsWire
- 2 days ago - What's Going On With Tilray Brands Stock Today? - Benzinga
- 2 days ago - Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts - GlobeNewsWire
- 3 days ago - What's Going On With Tilray Stock Today? - Benzinga
- 3 days ago - Is Tilray stock price rally a trap? history suggests selling - Invezz
- 3 days ago - Tilray Expands Hemp-Derived Delta-9 THC Beverage Lineup with 10mg Drinks from Fizzy Jane's and Happy Flower Brands - GlobeNewsWire
- 3 days ago - Tilray Brands: Is TLRY Stock The Next Big Thing? - Forbes
- 4 days ago - Tilray Surges 14% After Hours On Trump Cannabis Reclassification - Benzinga